Trial intelligence / Profile preview

Oxybutynin vs Tamsulosin for Pediatric Stent Discomfort

NCT02483793Withdrawn

Sponsor
Phoenix Children's
Start
Jul 2015
Primary completion
Dec 2016
Modality
Small Molecules
01

Overview

Randomised trial of tamsulosin in ureteral stent-related symptoms (USRS), sponsored by Phoenix Children's. Primary endpoints: Number of doses of pain medication used at 5 days and Pain scale based on the faces pain score at 5 days. Planned start Jul 2015; status: withdrawn.

02

Drugs

tamsulosin
03

Conditions

ureteral stent-related symptoms (USRS)

Beyond the preview

Go deeper on NCT02483793.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02483793.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call